PARATEK PHARMACEUTICALS for PARATEK PHARMACEUTICALS
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
FY 2026 Appropriations for DOD and HHS, focused on funding for development and procurement of medical countermeasures and antibiotics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BENJAMIN NOVAK New | — |
Health Issues HCR
FY 2026 Appropriations for DOD and HHS, focused on funding for development and procurement of medical countermeasures and antibiotics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BENJAMIN NOVAK New | — |
Disaster Planning/Emergencies DIS
FY 2026 Appropriations for DOD and HHS, focused on funding for development and procurement of medical countermeasures and antibiotics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BENJAMIN NOVAK New | — |
Homeland Security HOM
FY 2026 Appropriations for DOD and HHS, focused on funding for development and procurement of medical countermeasures and antibiotics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BENJAMIN NOVAK New | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| B-FLEXION GROUP HOLDINGS | Switzerland | Switzerland | 80.0% | — |
| ERNESTO BERTARELLI | Switzerland | Switzerland | 80.0% | — |
| B-FLEXION INTERNATIONAL HOLDINGS SA | Switzerland | Switzerland | 80.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.